Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
.png)
Newsletter Update
Clinical Diagnostics
AI / Machine Learning | January Round-Up
Read about the latest updates in the AI / ML space in the month of January.
February 5, 2025
Newsletter Update
Clinical Diagnostics
AI / Machine Learning | January Round-Up
Read about the latest updates in the AI / ML space in the month of January.
February 5, 2025
AI / Machine Learning
.png)
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | January Round-Up 2025
Read about the latest updates in the Next-Generation Therapeutics space in the month of January.
February 4, 2025
Newsletter Update
Pharma & Biotech
Next-Generation Therapeutics Newsletter | January Round-Up 2025
Read about the latest updates in the Next-Generation Therapeutics space in the month of January.
February 4, 2025
Next-Generation Therapeutics
DeciBio Q&A
Clinical Diagnostics
Radiomics: Advancing Precision Medicine and Clinical Impact – Interview with Václav Potesil from Optellum
Václav Potesil, CEO of Optellum, discusses how radiomics is transforming precision medicine by leveraging AI-driven imaging biomarkers to improve early disease detection, patient stratification, and clinical decision-making.
February 3, 2025
DeciBio Q&A
Clinical Diagnostics
Radiomics: Advancing Precision Medicine and Clinical Impact – Interview with Václav Potesil from Optellum
Václav Potesil, CEO of Optellum, discusses how radiomics is transforming precision medicine by leveraging AI-driven imaging biomarkers to improve early disease detection, patient stratification, and clinical decision-making.
February 3, 2025
Radiomics
AI / Machine Learning
DeciBio Q&A
Clinical Diagnostics
Q&A with Rehan Verjee, Co-Founder and CEO of Precede Biosciences Current Perspectives on Epigenomics in Diagnostics
We spoke with Rehan about his background, the role of epigenomics in liquid biopsy, and how it could shape the future of precision medicine.
January 29, 2025
DeciBio Q&A
Clinical Diagnostics
Q&A with Rehan Verjee, Co-Founder and CEO of Precede Biosciences Current Perspectives on Epigenomics in Diagnostics
We spoke with Rehan about his background, the role of epigenomics in liquid biopsy, and how it could shape the future of precision medicine.
January 29, 2025
Diagnostics Market
Clinical Diagnostics
Molecular Diagnostics
DeciBio News
Clinical Diagnostics
Worldwide Single Cell Analysis (SCA) Market Forecasted to Grow at 10% p.a., Reaching $2.1B by 2029 – Market Report by DeciBio Consulting LLC
This sixth edition of DeciBio’s single-cell analysis (SCA) report takes an updated and comprehensive look at the SCA landscape.
January 27, 2025
DeciBio News
Clinical Diagnostics
Worldwide Single Cell Analysis (SCA) Market Forecasted to Grow at 10% p.a., Reaching $2.1B by 2029 – Market Report by DeciBio Consulting LLC
This sixth edition of DeciBio’s single-cell analysis (SCA) report takes an updated and comprehensive look at the SCA landscape.
January 27, 2025
single cell analysis
Genomics Market
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | December Round-Up 2024
2024 ushered in a lot of LBx news! December closed out 2024 with several collaborations and partnerships.
January 23, 2025
Newsletter Update
Clinical Diagnostics
Liquid Biopsy | December Round-Up 2024
2024 ushered in a lot of LBx news! December closed out 2024 with several collaborations and partnerships.
January 23, 2025
Liquid Biopsy
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved